trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Atypical lobular hyperplasia is associated with an elevated risk of subsequent breast cancer.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
4 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that Atypical lobular hyperplasia is associated with an elevated risk of subsequent breast cancer?

Yes. Atypical lobular hyperplasia (ALH) is widely recognized in clinical guidelines and large-scale cohort studies as a significant high-risk lesion that indicates an elevated risk for the subsequent development of breast cancer.

Verdict: SUPPORTED · 4 sources for, 0 against · Last checked

The analysis

The retrieved literature consistently confirms that atypical lobular hyperplasia (ALH) is a high-risk benign breast lesion associated with an increased long-term risk of developing breast cancer, supporting the claim without contradictory evidence.

Evidence for · 4
Management of High-Risk Breast Lesions: A Comprehensive Update.
2026
States that atypical lobular hyperplasia (ALH) serves as a biomarker of long-term breast cancer risk.
Get citation
KW, Z., MK, K., EB, V., SA, C., K, C., K, D., M, E., AE, K., S, M., JH, P., W, Z., & M, B. (2026). Management of High-Risk Breast Lesions: A Comprehensive Update.. doi.org. https://doi.org/10.1093/jbi/wbag034

See more details
More for · 3
American Society of Breast Surgeons, Society of Breast Imaging, and College of American Pathology 2026 Guidelines for the Management of Proliferative Lesions With Atypia and Lobular Carcinoma In Situ.
2026
Confirms that the natural history of ALH indicates an association with an elevated future breast cancer risk.
Get citation
F, N., I, B., TA, K., SL, H., KH, A., S, B., HA, P., NM, J., JC, B., & K, Y. (2026). American Society of Breast Surgeons, Society of Breast Imaging, and College of American Pathology 2026 Guidelines for the Management of Proliferative Lesions With Atypia and Lobular Carcinoma In Situ.. doi.org. https://doi.org/10.1001/jamasurg.2026.3552

Advancing Evidence of the Associations between specific Benign Breast Diagnoses and Future Breast Cancer Risk.
2026
Demonstrates that proliferative changes with atypia, including ALH, are associated with significantly increased hazard ratios for subsequent invasive and in situ breast cancers.
Get citation
O, S., DL, W., AD, B., THM, K., BL, S., K, K., & DL, M. (2026). Advancing Evidence of the Associations between specific Benign Breast Diagnoses and Future Breast Cancer Risk.. doi.org. https://doi.org/10.1158/1055-9965.epi-26-0640

The Complex Path from Mammary Ductal Hyperplasia to Breast Cancer: Elevated Malignancy Risk in Atypical Forms.
2026
Notes that atypical lobular hyperplasia represents a proliferative lesion posing elevated risks for malignant transformation.
Get citation
BA, G., LP, M., AB, B., RT, S., E, D., ME, J., C, C., TC, P., MM, O., A, M., & AS, Ș. (2026). The Complex Path from Mammary Ductal Hyperplasia to Breast Cancer: Elevated Malignancy Risk in Atypical Forms.. doi.org. https://doi.org/10.3390/biomedicines14020349

What does the evidence say?

The retrieved literature consistently confirms that atypical lobular hyperplasia (ALH) is a high-risk benign breast lesion associated with an increased long-term risk of developing breast cancer, supporting the claim without contradictory evidence.

Receipt History
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work